United States Stem Cell Therapy Market Report & Forecast 2021-2027

Publisher Name :
Date: 27-Sep-2021
No. of pages: 93
Inquire Before Buying

United States Stem Cell Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Stem Cell Therapy Market Segment Percentages, By Type, 2020 (%)

- Autologous

- Allogeneic

United States Stem Cell Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Stem Cell Therapy Market Segment Percentages, By Application, 2020 (%)

- Musculoskeletal Disorder

- Wounds & Injuries

- Cornea

- Cardiovascular Diseases

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Stem Cell Therapy revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Stem Cell Therapy revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Osiris Therapeutics

- NuVasive

- Chiesi Pharmaceuticals

- JCR Pharmaceutical

- Pharmicell

- Medi-post

- Anterogen

- Molmed

- Takeda (TiGenix)

United States Stem Cell Therapy Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Stem Cell Therapy Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Stem Cell Therapy Overall Market Size
2.1 United States Stem Cell Therapy Market Size: 2021 VS 2027
2.2 United States Stem Cell Therapy Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stem Cell Therapy Players in United States Market
3.2 Top United States Stem Cell Therapy Companies Ranked by Revenue
3.3 United States Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Stem Cell Therapy Companies in United States Market, by Revenue in 2020
3.5 Companies Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cell Therapy Players in United States Market
3.6.1 List of Tier 1 Stem Cell Therapy Companies in United States
3.6.2 List of Tier 2 and Tier 3 Stem Cell Therapy Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Stem Cell Therapy Market Size Markets, 2021 & 2027
4.1.2 Autologous
4.1.3 Allogeneic
4.2 By Type - United States Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type - United States Stem Cell Therapy Revenue, 2016-2021
4.2.2 By Type - United States Stem Cell Therapy Revenue, 2022-2027
4.2.3 By Type - United States Stem Cell Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Stem Cell Therapy Market Size, 2021 & 2027
5.1.2 Musculoskeletal Disorder
5.1.3 Wounds & Injuries
5.1.4 Cornea
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 By Application - United States Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application - United States Stem Cell Therapy Revenue, 2016-2021
5.2.2 By Application - United States Stem Cell Therapy Revenue, 2022-2027
5.2.3 By Application - United States Stem Cell Therapy Revenue Market Share, 2016-2027
6 Stem Cell Therapy Companies Profiles
6.1 Osiris Therapeutics
6.1.1 Osiris Therapeutics Company Details
6.1.2 Osiris Therapeutics Business Overview
6.1.3 Osiris Therapeutics Stem Cell Therapy Introduction
6.1.4 Osiris Therapeutics Stem Cell Therapy Revenue in United States Market (2016-2021)
6.1.5 Osiris Therapeutics Recent Developments
6.2 NuVasive
6.2.1 NuVasive Company Details
6.2.2 NuVasive Business Overview
6.2.3 NuVasive Stem Cell Therapy Introduction
6.2.4 NuVasive Stem Cell Therapy Revenue in United States Market (2016-2021)
6.2.5 NuVasive Recent Developments
6.3 Chiesi Pharmaceuticals
6.3.1 Chiesi Pharmaceuticals Company Details
6.3.2 Chiesi Pharmaceuticals Business Overview
6.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Introduction
6.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Revenue in United States Market (2016-2021)
6.3.5 Chiesi Pharmaceuticals Recent Developments
6.4 JCR Pharmaceutical
6.4.1 JCR Pharmaceutical Company Details
6.4.2 JCR Pharmaceutical Business Overview
6.4.3 JCR Pharmaceutical Stem Cell Therapy Introduction
6.4.4 JCR Pharmaceutical Stem Cell Therapy Revenue in United States Market (2016-2021)
6.4.5 JCR Pharmaceutical Recent Developments
6.5 Pharmicell
6.5.1 Pharmicell Company Details
6.5.2 Pharmicell Business Overview
6.5.3 Pharmicell Stem Cell Therapy Introduction
6.5.4 Pharmicell Stem Cell Therapy Revenue in United States Market (2016-2021)
6.5.5 Pharmicell Recent Developments
6.6 Medi-post
6.6.1 Medi-post Company Details
6.6.2 Medi-post Business Overview
6.6.3 Medi-post Stem Cell Therapy Introduction
6.6.4 Medi-post Stem Cell Therapy Revenue in United States Market (2016-2021)
6.6.5 Medi-post Recent Developments
6.7 Anterogen
6.7.1 Anterogen Company Details
6.7.2 Anterogen Business Overview
6.7.3 Anterogen Stem Cell Therapy Introduction
6.7.4 Anterogen Stem Cell Therapy Revenue in United States Market (2016-2021)
6.7.5 Anterogen Recent Developments
6.8 Molmed
6.8.1 Molmed Company Details
6.8.2 Molmed Business Overview
6.8.3 Molmed Stem Cell Therapy Introduction
6.8.4 Molmed Stem Cell Therapy Revenue in United States Market (2016-2021)
6.8.5 Molmed Recent Developments
6.9 Takeda (TiGenix)
6.9.1 Takeda (TiGenix) Company Details
6.9.2 Takeda (TiGenix) Business Overview
6.9.3 Takeda (TiGenix) Stem Cell Therapy Introduction
6.9.4 Takeda (TiGenix) Stem Cell Therapy Revenue in United States Market (2016-2021)
6.9.5 Takeda (TiGenix) Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Stem Cell Therapy Market Opportunities & Trends in United States Market
Table 2. Stem Cell Therapy Market Drivers in United States Market
Table 3. Stem Cell Therapy Market Restraints in United States Market
Table 4. Key Players of Stem Cell Therapy in United States Market
Table 5. Top Stem Cell Therapy Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Stem Cell Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Stem Cell Therapy Revenue Share by Companies, 2016-2021
Table 8. Companies Stem Cell Therapy Product Type
Table 9. List of Tier 1 Stem Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Stem Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Stem Cell Therapy Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Stem Cell Therapy Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Stem Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Stem Cell Therapy Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Stem Cell Therapy Revenue (US$, Mn), 2022-2027
Table 17. Osiris Therapeutics Company Details
Table 18. Osiris Therapeutics Business Overview
Table 19. Osiris Therapeutics Stem Cell Therapy Product
Table 20. Osiris Therapeutics Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Osiris Therapeutics Recent Developments
Table 22. NuVasive Company Details
Table 23. NuVasive Business Overview
Table 24. NuVasive Stem Cell Therapy Product
Table 25. NuVasive Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. NuVasive Recent Developments
Table 27. Chiesi Pharmaceuticals Company Details
Table 28. Chiesi Pharmaceuticals Business Overview
Table 29. Chiesi Pharmaceuticals Stem Cell Therapy Product
Table 30. Chiesi Pharmaceuticals Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Chiesi Pharmaceuticals Recent Developments
Table 32. JCR Pharmaceutical Company Details
Table 33. JCR Pharmaceutical Business Overview
Table 34. JCR Pharmaceutical Stem Cell Therapy Product
Table 35. JCR Pharmaceutical Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. JCR Pharmaceutical Recent Developments
Table 37. Pharmicell Company Details
Table 38. Pharmicell Business Overview
Table 39. Pharmicell Stem Cell Therapy Product
Table 40. Pharmicell Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Pharmicell Recent Developments
Table 42. Medi-post Company Details
Table 43. Medi-post Business Overview
Table 44. Medi-post Stem Cell Therapy Product
Table 45. Medi-post Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Medi-post Recent Developments
Table 47. Anterogen Company Details
Table 48. Anterogen Business Overview
Table 49. Anterogen Stem Cell Therapy Product
Table 50. Anterogen Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Anterogen Recent Developments
Table 52. Molmed Company Details
Table 53. Molmed Business Overview
Table 54. Molmed Stem Cell Therapy Product
Table 55. Molmed Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Molmed Recent Developments
Table 57. Takeda (TiGenix) Company Details
Table 58. Takeda (TiGenix) Business Overview
Table 59. Takeda (TiGenix) Stem Cell Therapy Product
Table 60. Takeda (TiGenix) Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Takeda (TiGenix) Recent Developments
List of Figures
Figure 1. Stem Cell Therapy Segment by Type
Figure 2. Stem Cell Therapy Segment by Application
Figure 3. United States Stem Cell Therapy Market Overview: 2020
Figure 4. United States Stem Cell Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Stem Cell Therapy Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Stem Cell Therapy Revenue in 2020
Figure 7. By Type - United States Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 8. By Application - United States Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 9. Osiris Therapeutics Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. NuVasive Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Chiesi Pharmaceuticals Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. JCR Pharmaceutical Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Pharmicell Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Medi-post Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Anterogen Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Molmed Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Takeda (TiGenix) Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Animal Stem Cell Therapy Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 89
    Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing The sample to concentrate The stem cells. Finally, The therapy includes transferring The stem cells into The injured site ......
  • Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 104
    According to our LPI (LP Information) latest study, the global Mesenchymal Stem Cells market size was valued at US$ 202.6 million in 2023. With growing demand in downstream market, the Mesenchymal Stem Cells is forecast to a readjusted size of US$ 278.8 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Mesenchymal Stem Cells market. Mesenchymal Stem Cells are expected to show stable growth in the future market. How......
  • Global Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Stem Cells market size was valued at US$ 2693.1 million in 2023. With growing demand in downstream market, the Stem Cells is forecast to a readjusted size of US$ 5700.6 million by 2030 with a CAGR of 11.3% during review period. The research report highlights the growth potential of the global Stem Cells market. Stem Cells are expected to show stable growth in the future market. However, product differentiation, reducing costs......
  • Global Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Stem Cell Therapy market size was valued at US$ 469.1 million in 2023. With growing demand in downstream market, the Stem Cell Therapy is forecast to a readjusted size of US$ 1724 million by 2030 with a CAGR of 20.4% during review period. The research report highlights the growth potential of the global Stem Cell Therapy market. Stem Cell Therapy are expected to show stable growth in the future market. However, product differ......
  • Global Animal Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Animal Stem Cell Therapy market size was valued at US$ 199.3 million in 2023. With growing demand in downstream market, the Animal Stem Cell Therapy is forecast to a readjusted size of US$ 476.2 million by 2030 with a CAGR of 13.2% during review period. The research report highlights the growth potential of the global Animal Stem Cell Therapy market. Animal Stem Cell Therapy are expected to show stable growth in the future ma......
  • Global Stem Cell Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Stem Cell market: According to our latest research, the global Stem Cell market looks promising in the next 5 years. As of 2022, the global Stem Cell market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells. ......
  • Global Animal Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Animal Stem Cell Therapy market size was valued at USD 209.7 million in 2023 and is forecast to a readjusted size of USD 469.9 million by 2030 with a CAGR of 12.2% during review period. Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or di......
  • Global Hematopoietic Stem Cells Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Hematopoietic Stem Cells market: According to our latest research, the global Hematopoietic Stem Cells market looks promising in the next 5 years. As of 2022, the global Hematopoietic Stem Cells market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Adipose Stem Cells (ASCS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Adipose Stem Cells (ASCS) market: According to our latest research, the global Adipose Stem Cells (ASCS) market looks promising in the next 5 years. As of 2022, the global Adipose Stem Cells (ASCS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs